Morrisville life science firm TARGAN raises $35M Series C financing ahead of ‘full commercialization’
Morrisville-headquartered biotechnology firm TARGAN has raised $35 million in Series C funding from new and existing investors.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
